Pharmaceutical Business Review
Anonymous User | Login

BioSante Pharmaceuticals Files NDA For Elestrin In Israel

Published: 23-Jun-2009

Elestrin to be used for the treatment of vasomotor symptoms associated with menopause

PharmaSwiss, Israeli licensee of BioSante Pharmaceuticals, has submitted a new drug application (NDA) for Elestrin in Israel.

The Elestrin filing is based on BioSante’ FDA approved NDA for the treatment of moderate-to-severe vasomotor symptoms (hot flashes), associated with menopause. According to the agreement, PharmaSwiss is responsible for regulatory and marketing activities in Israel.

Stephen Simes, President and CEO, BioSante Pharmaceuticals, said: “We believe PharmaSwiss is in an excellent position to capture an important share of the Israeli estrogen therapy market once Elestrin is approved. We look forward to working with PharmaSwiss on the successful marketing of Elestrin in Israel, and expanding the distribution of Elestrin beyond the US.”

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Almac

Drug Development Solutions ...

GRACO

World Leader in Fluid Handling Systems and Components ...

Burkert Fluid Control Systems

Fluid and Gas Control Systems ...

eResearch Technology

Provider of Technology and Services ...

Umicore Precious Metals Chemistry

Chemicals and Catalysts for Industrial Applications ...

PFC Pharma Focus

Planning And Conducting Clinical Phase I To IV Studies ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

GRACO's New FDA Pumps

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

GRACO's New Hydra-Clean

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

GRACO's New 1590 & 3150 Pumps

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

Customer Testimonial – Astra Zeneca

From the control room to the downstream processing area and with an eye on utilities servi ...

Hygienic Processing

From the control room to the downstream processing area and with an eye on utilities servi ...

Related Companies

Noven Pharmaceuticals, Inc.

Noven Pharmaceuticals, Inc. (Noven) is a specialty pharmaceutical company engaged in t ...

Auxilium Pharmaceuticals, Inc.

Auxilium Pharmaceuticals, Inc. (Auxilium) is a specialty biopharmaceutical company focu ...

Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals (Watson) is a specialty pharmaceutical company engaged in the de ...

BioSante Pharmaceuticals, Inc.

BioSante Pharmaceuticals, Inc. (BioSante) is focused on developing products for female ...

Suppliers Product News

Almac Completes Phase One of Its Expansion Plan to Pharma Services Facilities

New $15m facility will "meet growing business need for its integrated product development and commercial services."

ERT Launches New Online Gateway to Improve Cardiac Safety in Clinical Trials

ERT, a leading provider of centralized ECG, ePRO, eClinical technology and other services to the biopharmaceutical, medical device and related industries, announced today the launch of a unique online web interface – My Study Portal.

ERT Officials Ring the NASDAQ Closing Bell

ERT (NASDAQ: ERES), a leading provider of centralized ECG and eClinical technology, ePRO and other services to the biopharmaceutical, medical device and related industries, closed the stock market on 18 June by ringing the famous NASDAQ bell.

ERT Relocates Customer Care Team to Provide Stronger Client Support

ERT a leading provider of centralized ECG, ePRO, eClinical technology and other services to the biopharmaceutical, medical device and related industries, is to move its dedicated customer care team to its new state-of-the-art headquarters and logistics operations in Philadelphia.

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address